Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comfrey Root Extract Plus Methyl Nicotinate vs Methyl Nicotinate vs Placebo in Acute Back Pain
DRKS00000326Phase 3Completed
- Sponsor
- Merck Selbstmedikation
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of comfrey root extract, methylnicotinate in lumbodynia (LBP), None, sponsored by Merck Selbstmedikation. Started Jan 2010; status: completed.
02
Drugs
comfrey root extractmethylnicotinate
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on DRKS00000326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000326.